Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of intravenous alendronate.
Cocquyt V, Kline WF, Gertz BJ, Van Belle SJ, Holland SD, DeSmet M, Quan H, Vyas KP, Zhang KE, De Grève J, Porras AG. Cocquyt V, et al. Among authors: quan h. J Clin Pharmacol. 1999 Apr;39(4):385-93. doi: 10.1177/00912709922007958. J Clin Pharmacol. 1999. PMID: 10197297 Clinical Trial.
Studies of the oral bioavailability of alendronate.
Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG. Gertz BJ, et al. Among authors: quan h. Clin Pharmacol Ther. 1995 Sep;58(3):288-98. doi: 10.1016/0009-9236(95)90245-7. Clin Pharmacol Ther. 1995. PMID: 7554702 Clinical Trial.
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL. Swan SK, et al. Among authors: quan h. Ann Intern Med. 2000 Jul 4;133(1):1-9. doi: 10.7326/0003-4819-133-1-200007040-00002. Ann Intern Med. 2000. PMID: 10877734 Clinical Trial.
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M. Liberman UA, et al. Among authors: quan h. N Engl J Med. 1995 Nov 30;333(22):1437-43. doi: 10.1056/NEJM199511303332201. N Engl J Med. 1995. PMID: 7477143 Free article. Clinical Trial.
1,277 results